Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients

BACKGROUND: The increase in serum phosphorus level is an independent risk factor for mortality in patients with chronic renal failure or undergoing dialysis due to end-stage renal disease. Proton pump inhibitors (PPI) are the general name given to agents used to suppress stomach acid. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cekiç, Deniz, Sipahi, Savaş, Emir Arman, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646360/
https://www.ncbi.nlm.nih.gov/pubmed/38024165
http://dx.doi.org/10.22088/cjim.14.4.737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646360/
https://www.ncbi.nlm.nih.gov/pubmed/38024165
http://dx.doi.org/10.22088/cjim.14.4.737

Ejemplares similares